Brief: Docmorris Reaffirms EBITDA Breakeven In 2026

DocMorris AG

19/03/2026 06:03

March 19 (Reuters) - DOCMORRIS AG DOCM.S:

ACHIEVES 2025 TARGETS – FOCUS ON PROFITABILITY, GROWTH AND EXPANSION OF DIGITAL HEALTH PLATFORM

2025 CONSOLIDATED REVENUE UP 12.4% IN LOCAL CURRENCY TO CHF 1,124.5 MILLION

2025 ADJUSTED EBITDA IMPROVES SLIGHTLY TO MINUS CHF 48.2 MILLION

OUTLOOK: MANAGEMENT REAFFIRMS EBITDA BREAKEVEN IN COURSE OF 2026

OUTLOOK 2026: EXTERNAL REVENUE GROWTH IN MID-SINGLE-DIGIT TO LOW TEENS PERCENTAGE RANGE;

OUTLOOK 2026: ADJUSTED EBITDA OF MINUS CHF 10 MILLION TO MINUS CHF 25 MILLION;

OUTLOOK 2026: CAPITAL EXPENDITURE OF AROUND CHF 30 MILLION.

DOCMORRIS WILL CLOSE LUDWIGSHAFEN SITE BY END OF JUNE 2026

Source text: ID:nEQ3dvFWva

Further company coverage: DOCM.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))